HIV vac­cine trial could be ‘fi­nal nail in the cof­fin’ for dis­ease

Daily Freeman (Kingston, NY) - - NATION + WORLD -

JO­HAN­NES­BURG >> A new vac­cine against HIV, to be tested Wed­nes­day in a trial to be launched in South Africa, could be “the fi­nal nail in the cof­fin” for the dis­ease if it is suc­cess­ful, sci­en­tists say.

The study, called HVTN 702, aims to en­roll 5,400 sex­u­ally ac­tive men and women aged be­tween 18 and 35 at 15 sites across South Africa.

It will be the largest and most ad­vanced HIV vac­cine clin­i­cal trial to take place in South Africa, where more than 1,000 peo­ple a day are in­fected with HIV.

“If de­ployed along­side our cur­rent ar­mory of proven HIV pre­ven­tion tools, a safe and ef­fec­tive vac­cine could be the fi­nal nail in the cof­fin for HIV,” An­thony Fauci, di­rec­tor of the U.S. govern­ment’s Na­tional In­sti­tute of Al­lergy and In­fec­tious Dis­eases, said in a state­ment.

The new vac­cine is based on a 2009 trial in Thai­land, that was found to be 31.2 per­cent ef­fec­tive at pre­vent­ing HIV in­fec­tion.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.